Depression affects about 1 in every 5 individual in the U.S. According to WHO (world health organization and center for disease control) at present an estimated about 350 million people worldwide are affected with depression. In the year 2017, drugs for depression were valued at approximately US$ 6,500 Million and are anticipated to register a CAGR of over -2% from 2018 to 2026 to reach value of approximately over US$ 5000 Million by 2026. Geographically, North America being the home company of many of the global depression drugs market is likely responsible for the dominance of market share of the region. Europe held the second leading share of the global depression drugs market in 2017, which can be ascribed to the increase in research and development activities on depression drugs in the region. The depression drugs market in Middle East & Africa is anticipated to grow at a significant rate during the predicted period.
Depression, Depression signs and symptoms, Bi polar disorder, post-natal depression, seasonal effective disorder, Treatments for depression, depression management and therapies, Depression and anxiety, Geriatric depression, Mental Health, Stress management
Psychiatrists, Psychologists, Researchers, Health care professionals, Professors, Industrial Experts, Mental health Nurses, Lecturers and Students from Academia, Students from Academia in the research of Psychology
Depression | Depression symptoms | Depression diagnosis | Depression treatment | Anxiety |Stress | Depression awareness |Depression hotline |
68 Quai de la Seine, 75019 Paris, France